Aleafia Health Posts Revenues of $4.95 Million for Third Quarter

Aleafia Health (TSX: ALEF) reported its third quarter financial results this morning, posting net revenues of $4.95 million, an increase of 29.1% on a quarter over quarter basis. Total cannabis sales amounted to $4.15 million before excise taxes were deducted.

It should be noted that within its press release, Aleafia identified top line revenue gross of excise taxes, thus the discrepancy in reported figures. Most peers in the sector report net revenues for consistency.

Aleafia reported a gross profit before fair value adjustments of $2.03 million for the quarter. However, thanks in part to its outdoor cannabis cultivation, a $10.36 million bump was given to gross profit from the unrealized gain on fair value of biological assets. Thanks to this bump, the firm was able to report a net income of $1.85 million for the quarter.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Expenses during the quarter saw a significant decrease, from $12.06 million to $8.45 million. This is primarily as a result of share based payments, which declined from $4.21 million to $0.41 million in the current quarter. Wages and benefits came in at $2.48 million, up from $1.02 million in the previous quarter, while general and administrative expenses rose to $2.32 million from $1.72 million.

Operating activities during the quarter amounted to $7.92 million, resulting in a cash flow negative operation despite a posted net income. Aleafia’s total cash position decreased from $57.97 million to $51.58 million during the quarter. Accounts receivable continued to climb during the third quarter, from $6.28 million to $8.46 million. Outstanding receivables currently account for 170.82% of current quarter net revenues, suggesting that the firm is having significant issues collecting funds owed. Inventory also rose during the quarter from $4.25 million to $7.81 million.

Accounts payable rose during the quarter from $6.71 million to $10.24 million.

Aleafia identified within its news release that its average net selling price for medical cannabis was $15.11 per gram, $6.40 for adult-use product, and $6.00 for wholesale product. The firm has not previously provided this breakdown within its filings. Within the interim financials, Aleafia identified an “average transfer price per gram” for estimating purposes of $4.50 for indoor product and $1.25 for outdoor product. Within the previous quarter the firm identified that the average selling price per gram within its estimates is $3.40.

Aleafia Health closed yesterdays session at $0.92 on the TSX. Today’s financial release follows yesterdays announcement of outdoor harvest yields for the firm.


Information for this briefing was found via Sedar and Aleafia Health. The author has no affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Outdoor Cannabis Cultivation Has Arrived in Canada

Outdoor grow is coming to Canada in a hurry. Health Canada, the regulating body for...

Monday, June 3, 2019, 07:00:53 AM

Numerous Canadian Licensed Producers See Additional Licenses Granted

A number of Canadian licensed producers announced Health Canada approvals for expanded facilities this morning,...

Monday, October 7, 2019, 09:54:10 AM

Aleafia Health Reports Q1 2020 Revenues of $14.6 Million, Net Loss of $6.2 Million

Aleafia Health (TSX: ALEF) this morning reported its first quarter 2020 financial results, reporting net...

Wednesday, May 13, 2020, 08:50:29 AM

Aleafia Health Begins Strategic Review Process As Debt Comes Due

Lenders within the Canadian cannabis market appear to be nearing their wits end as they...

Thursday, May 25, 2023, 09:08:19 AM

Aleafia Health Repays Debentures, Releases Extremely Vague Commentary On Q4 Results

Aleafia Health (TSX: AH) confirmed this morning that, as previously announced, the company has managed...

Tuesday, February 2, 2021, 08:20:18 AM